Does ODEVIXIBAT Cause Product dose omission issue? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Product dose omission issue have been filed in association with ODEVIXIBAT (BYLVAY). This represents 7.2% of all adverse event reports for ODEVIXIBAT.
16
Reports of Product dose omission issue with ODEVIXIBAT
7.2%
of all ODEVIXIBAT reports
0
Deaths
2
Hospitalizations
How Dangerous Is Product dose omission issue From ODEVIXIBAT?
Of the 16 reports, 2 (12.5%) required hospitalization, and 1 (6.3%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ODEVIXIBAT. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does ODEVIXIBAT Cause?
Diarrhoea (65)
Pruritus (55)
Off label use (33)
Drug ineffective (26)
Abdominal pain (17)
Abdominal pain upper (17)
Vomiting (14)
Blood bilirubin increased (10)
Hepatic enzyme increased (10)
Nausea (10)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which ODEVIXIBAT Alternatives Have Lower Product dose omission issue Risk?
ODEVIXIBAT vs OFATUMUMAB
ODEVIXIBAT vs OFLOXACIN
ODEVIXIBAT vs OLANZAPINE
ODEVIXIBAT vs OLANZAPINE\SAMIDORPHAN L-MALATE
ODEVIXIBAT vs OLAPARIB